BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18178494)

  • 21. Efficacy and safety evaluation of ciclesonide in subjects with mild-to-moderate asthma not currently using inhaled corticosteroids.
    Berger WE; Kerwin E; Bernstein DI; Pedinoff A; Bensch G; Karafilidis J
    Allergy Asthma Proc; 2009; 30(3):304-14. PubMed ID: 19549432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety evaluation of ciclesonide in mild-to-moderate persistent asthma previously treated with inhaled corticosteroids.
    Meltzer EO; Korenblat PE; Weinstein SF; Noonan M; Karafilidis J
    Allergy Asthma Proc; 2009; 30(3):293-303. PubMed ID: 19549431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma.
    Lipworth BJ; Kaliner MA; LaForce CF; Baker JW; Kaiser HB; Amin D; Kundu S; Williams JE; Engelstaetter R; Banerji DD
    Ann Allergy Asthma Immunol; 2005 Apr; 94(4):465-72. PubMed ID: 15875528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of a step-down dose of once-daily ciclesonide with a continued dose of twice-daily fluticasone propionate in maintaining control of asthma.
    Knox A; Langan J; Martinot JB; Gruss C; Häfner D
    Curr Med Res Opin; 2007 Oct; 23(10):2387-94. PubMed ID: 17714607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative study of inhaled ciclesonide 160 microg/day and fluticasone propionate 176 microg/day in children with asthma.
    Pedersen S; Garcia Garcia ML; Manjra A; Theron I; Engelstätter R
    Pediatr Pulmonol; 2006 Oct; 41(10):954-61. PubMed ID: 16868976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Once-daily ciclesonide in children: efficacy and safety in asthma.
    Gelfand EW; Georgitis JW; Noonan M; Ruff ME
    J Pediatr; 2006 Mar; 148(3):377-83. PubMed ID: 16615971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the effect of low-dose ciclesonide and fixed-dose fluticasone propionate and salmeterol combination on long-term asthma control.
    Postma DS; O'Byrne PM; Pedersen S
    Chest; 2011 Feb; 139(2):311-318. PubMed ID: 21088114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Similar efficacy of ciclesonide versus prednisolone to treat asthma worsening after steroid tapering.
    van den Berge M; Arshad SH; Ind PW; Magnussen H; Hamelmann E; Kanniess F; Postma DS
    Respir Med; 2009 Aug; 103(8):1216-23. PubMed ID: 19297141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Similar efficacy of ciclesonide once daily versus fluticasone propionate twice daily in patients with persistent asthma.
    Magnussen H; Hofman J; Staneta P; Lawo JP; Hellwig M; Engelstätter R
    J Asthma; 2007 Sep; 44(7):555-63. PubMed ID: 17885859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
    Medley H; Orozco S; Allen A
    Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of a 12-week therapy with a new formulation of fluticasone propionate at doses of 125 and 250 μg administered through a new generation cyclohaler twice daily, in comparison to fluticasone propionate 500 μg dry powder inhaler twice daily in patients with moderate asthma.
    Kupryś-Lipińska I; Tworek D; Vanderbist F; Bocheńska-Marciniak M; Kuna P
    Pneumonol Alergol Pol; 2013; 81(6):527-36. PubMed ID: 24142782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5'monophosphate in asthmatic patients.
    Derom E; Van De Velde V; Marissens S; Engelstätter R; Vincken W; Pauwels R
    Pulm Pharmacol Ther; 2005; 18(5):328-36. PubMed ID: 15939311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma.
    Lee DK; Haggart K; Currie GP; Bates CE; Lipworth BJ
    Br J Clin Pharmacol; 2004 Jul; 58(1):26-33. PubMed ID: 15206989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M;
    Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM; Boulet LP; Follows RM
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma.
    Derom E; Louis R; Tiesler C; Engelstätter R; Kaufman JM; Joos GF
    Eur Respir J; 2009 Jun; 33(6):1277-86. PubMed ID: 19164356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of three ciclesonide doses vs placebo in children with asthma: the RAINBOW study.
    Pedersen S; Potter P; Dachev S; Bosheva M; Kaczmarek J; Springer E; Dunkel J; Engelstätter R
    Respir Med; 2010 Nov; 104(11):1618-28. PubMed ID: 20619624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and tolerability of salmeterol/fluticasone propionate versus fluticasone propionate in asthma patients: a randomized, double-blind study.
    Lee YS; Lin HC; Huang CD; Lee KY; Liu CY; Yu CT; Wang CH; Kuo HP
    Chang Gung Med J; 2011; 34(4):382-94. PubMed ID: 21880193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.